Article

The discovery and evaluation of treatment stratification biomarkers in epithelial ovarian cancer

2014-01-01

Abstract excerpt

Background: Epithelial ovarian cancer (EOC) has the poorest survival outcomes for all gynaecological malignancies. Despite emerging knowledge on the heterogeneity of the disease the majority of patients are initially treated the same. Biomarkers which could predict treatment response would greatly enhance patient care. Results: Differential DNA methylation analysis of serous EOC tumours identified 180 loci signifi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: dc4401a9-8b8b-5313-abc2-11a602d48011
DOI: 10.25560/26145

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The discovery and evaluation of treatment stratification biomarkers in epithelial ovarian cancerDOI 10.25560/26145Read

Epigenetic Regulation of the Homeobox Gene MSX1 Associates with Platinum-Resistant Disease in High-Grade Serous Epithelial Ovarian CancerSemantic proximity Read

DNA methylation changes in ovarian cancer: Implications for early diagnosis, prognosis and treatmentSemantic proximity Read

Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancerSemantic proximity Read

Methylation and ovarian cancer: Can DNA methylation be of diagnostic use? (Review)Semantic proximity Read

Molecular Characterization of Non-responders to Chemotherapy in Serous Ovarian Cancer.Semantic proximity Read

Methylomic Analysis of Ovarian Cancers Identifies Tumor-Specific Alterations Readily Detectable in Early Precursor LesionsSemantic proximity Read

Exploration of differential methylation-driven genes to identify key epigenetic genes for prognosis of ovarian serous cystadenocarcinomaSemantic proximity Read

Methylome analysis of extreme chemoresponsive patients identifies novel markers of platinum sensitivity in high-grade serous ovarian cancerSemantic proximity Read

Differential DNA methylation in high-grade serous ovarian cancer (HGSOC) is associated with tumor behaviorSemantic proximity Read

Methylation of MYLK3 gene promoter region: a biomarker to stratify surgical care in ovarian cancer in a multicentre studySemantic proximity Read

DNA Methylation and Transcriptomic Features are Preserved Throughout Disease Recurrence and Chemoresistance in High Grade Serous Ovarian CancersSemantic proximity Read

Epigenetic biomarkers in epithelial ovarian cancer.Semantic proximity Read